Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 19 | 2024 | 2303 | 1.450 |
Why?
|
| Papillomavirus Vaccines | 7 | 2019 | 151 | 0.850 |
Why?
|
| Anti-Anxiety Agents | 2 | 2018 | 15 | 0.730 |
Why?
|
| Parents | 6 | 2019 | 329 | 0.690 |
Why?
|
| Papillomavirus Infections | 7 | 2019 | 336 | 0.660 |
Why?
|
| Alzheimer Disease | 4 | 2022 | 905 | 0.650 |
Why?
|
| Florida | 13 | 2024 | 410 | 0.600 |
Why?
|
| Vaccination | 5 | 2024 | 288 | 0.540 |
Why?
|
| Residence Characteristics | 6 | 2022 | 322 | 0.470 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 404 | 0.470 |
Why?
|
| Humans | 48 | 2024 | 37093 | 0.430 |
Why?
|
| Female | 34 | 2023 | 20969 | 0.400 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2022 | 34 | 0.400 |
Why?
|
| Alcohol Drinking | 4 | 2022 | 519 | 0.360 |
Why?
|
| Male | 28 | 2023 | 20025 | 0.350 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2018 | 277 | 0.340 |
Why?
|
| Adult | 23 | 2024 | 11712 | 0.340 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 61 | 0.330 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2020 | 864 | 0.330 |
Why?
|
| Sex Factors | 4 | 2021 | 898 | 0.320 |
Why?
|
| Apolipoprotein E4 | 2 | 2018 | 47 | 0.320 |
Why?
|
| Cross-Sectional Studies | 12 | 2024 | 2721 | 0.310 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 420 | 0.310 |
Why?
|
| Adolescent | 16 | 2022 | 5363 | 0.300 |
Why?
|
| Viral Load | 4 | 2022 | 312 | 0.300 |
Why?
|
| Middle Aged | 17 | 2023 | 10129 | 0.270 |
Why?
|
| Young Adult | 12 | 2023 | 4268 | 0.260 |
Why?
|
| Smoking Cessation | 2 | 2022 | 517 | 0.250 |
Why?
|
| Emigrants and Immigrants | 2 | 2019 | 137 | 0.250 |
Why?
|
| Employment | 3 | 2021 | 76 | 0.250 |
Why?
|
| Pyridoxal Phosphate | 2 | 2022 | 11 | 0.250 |
Why?
|
| Vitamin B 6 | 2 | 2022 | 7 | 0.250 |
Why?
|
| Religion | 3 | 2019 | 87 | 0.220 |
Why?
|
| United States | 10 | 2024 | 4223 | 0.220 |
Why?
|
| Continuity of Patient Care | 2 | 2020 | 94 | 0.210 |
Why?
|
| Aged | 9 | 2022 | 6741 | 0.210 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 36 | 0.210 |
Why?
|
| Substance-Related Disorders | 3 | 2020 | 730 | 0.210 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2024 | 215 | 0.200 |
Why?
|
| Anomie | 1 | 2021 | 6 | 0.200 |
Why?
|
| Vitamin B Complex | 1 | 2021 | 5 | 0.190 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 52 | 0.190 |
Why?
|
| Child | 8 | 2022 | 3131 | 0.180 |
Why?
|
| Marketing | 1 | 2020 | 40 | 0.180 |
Why?
|
| Food Supply | 1 | 2021 | 112 | 0.180 |
Why?
|
| India | 5 | 2019 | 88 | 0.180 |
Why?
|
| Self Efficacy | 1 | 2021 | 184 | 0.170 |
Why?
|
| Trazodone | 1 | 2018 | 3 | 0.160 |
Why?
|
| Haiti | 3 | 2024 | 68 | 0.160 |
Why?
|
| Chronic Disease | 1 | 2021 | 484 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 494 | 0.160 |
Why?
|
| Mother-Child Relations | 2 | 2016 | 59 | 0.160 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 125 | 0.160 |
Why?
|
| Poverty | 1 | 2021 | 348 | 0.150 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 32 | 0.150 |
Why?
|
| Adolescent Behavior | 1 | 2020 | 253 | 0.150 |
Why?
|
| Autistic Disorder | 1 | 2018 | 37 | 0.150 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 2379 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 276 | 0.140 |
Why?
|
| Awareness | 1 | 2017 | 65 | 0.140 |
Why?
|
| Social Support | 1 | 2019 | 394 | 0.140 |
Why?
|
| Health Behavior | 1 | 2020 | 537 | 0.140 |
Why?
|
| Psychotherapy, Group | 1 | 2015 | 22 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2016 | 325 | 0.130 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 259 | 0.130 |
Why?
|
| Mood Disorders | 1 | 2015 | 48 | 0.130 |
Why?
|
| Health Policy | 1 | 2017 | 165 | 0.130 |
Why?
|
| HIV-1 | 1 | 2021 | 706 | 0.130 |
Why?
|
| Parental Consent | 1 | 2014 | 1 | 0.120 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 458 | 0.120 |
Why?
|
| Hippocampus | 1 | 2018 | 561 | 0.120 |
Why?
|
| Depression | 1 | 2020 | 712 | 0.120 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 885 | 0.120 |
Why?
|
| Health Status Disparities | 1 | 2020 | 642 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 481 | 0.110 |
Why?
|
| Prevalence | 3 | 2022 | 1455 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2016 | 451 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2019 | 583 | 0.110 |
Why?
|
| Rural Population | 3 | 2021 | 294 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 2 | 2023 | 147 | 0.110 |
Why?
|
| Mothers | 3 | 2022 | 181 | 0.100 |
Why?
|
| Urban Population | 3 | 2021 | 333 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 628 | 0.100 |
Why?
|
| Socioeconomic Factors | 3 | 2021 | 1067 | 0.100 |
Why?
|
| Alcoholism | 1 | 2014 | 240 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2016 | 609 | 0.100 |
Why?
|
| Schools | 3 | 2018 | 260 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 767 | 0.090 |
Why?
|
| Perception | 2 | 2022 | 195 | 0.090 |
Why?
|
| Logistic Models | 3 | 2021 | 923 | 0.090 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 242 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2015 | 681 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2021 | 221 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 974 | 0.080 |
Why?
|
| Minority Groups | 2 | 2024 | 596 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 643 | 0.070 |
Why?
|
| Nuclear Family | 2 | 2018 | 12 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2021 | 1492 | 0.070 |
Why?
|
| Educational Status | 2 | 2020 | 313 | 0.070 |
Why?
|
| Acculturation | 2 | 2019 | 188 | 0.070 |
Why?
|
| Genotype | 2 | 2018 | 730 | 0.060 |
Why?
|
| Professional-Patient Relations | 1 | 2023 | 48 | 0.060 |
Why?
|
| Social Values | 1 | 2022 | 30 | 0.050 |
Why?
|
| Risk Factors | 2 | 2021 | 3562 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2022 | 14 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 18 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2022 | 35 | 0.050 |
Why?
|
| Phosphates | 1 | 2022 | 51 | 0.050 |
Why?
|
| Cultural Characteristics | 1 | 2022 | 125 | 0.050 |
Why?
|
| Income | 1 | 2022 | 140 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2023 | 179 | 0.050 |
Why?
|
| Parenting | 1 | 2022 | 127 | 0.050 |
Why?
|
| Fentanyl | 1 | 2020 | 9 | 0.050 |
Why?
|
| Heroin | 1 | 2020 | 13 | 0.050 |
Why?
|
| Nepal | 1 | 2020 | 15 | 0.050 |
Why?
|
| Sleep | 1 | 2022 | 152 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2022 | 230 | 0.050 |
Why?
|
| AIDS Serodiagnosis | 1 | 2020 | 25 | 0.050 |
Why?
|
| Linear Models | 1 | 2021 | 275 | 0.040 |
Why?
|
| Financing, Government | 1 | 2020 | 19 | 0.040 |
Why?
|
| Psychometrics | 1 | 2021 | 318 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 121 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 197 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 339 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 935 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 739 | 0.040 |
Why?
|
| Organ Size | 1 | 2018 | 157 | 0.040 |
Why?
|
| Health Personnel | 1 | 2020 | 228 | 0.040 |
Why?
|
| Alleles | 1 | 2018 | 321 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 441 | 0.040 |
Why?
|
| Louisiana | 1 | 2017 | 43 | 0.040 |
Why?
|
| Alabama | 1 | 2017 | 51 | 0.040 |
Why?
|
| Mandatory Programs | 1 | 2016 | 4 | 0.040 |
Why?
|
| Virginia | 1 | 2016 | 10 | 0.040 |
Why?
|
| South Carolina | 1 | 2016 | 25 | 0.040 |
Why?
|
| Crime | 1 | 2016 | 26 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 1033 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2018 | 534 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 400 | 0.040 |
Why?
|
| Spouse Abuse | 1 | 2016 | 43 | 0.040 |
Why?
|
| Tennessee | 1 | 2016 | 70 | 0.040 |
Why?
|
| Physician's Role | 1 | 2016 | 38 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 267 | 0.030 |
Why?
|
| Condoms | 1 | 2016 | 135 | 0.030 |
Why?
|
| Smoking | 1 | 2022 | 940 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 601 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 560 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 110 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 114 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 1346 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2014 | 61 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2015 | 167 | 0.030 |
Why?
|
| Marital Status | 1 | 2014 | 40 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 380 | 0.030 |
Why?
|
| School Health Services | 1 | 2014 | 81 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 303 | 0.030 |
Why?
|
| Students | 1 | 2018 | 519 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1130 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1369 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 854 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1378 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 2026 | 0.020 |
Why?
|